NCT02236520View on ClinicalTrials.gov

Tissue Sodium in Pre-hypertensive Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Hypertension
Interventions
DRUG

Spironolactone

DRUG

Chlorthalidone

DIETARY_SUPPLEMENT

Diet

DRUG

Placebo

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Vanderbilt University

OTHER

NCT02236520 - Tissue Sodium in Pre-hypertensive Patients | Biotech Hunter | Biotech Hunter